Kitty Yale

EVP and Chief Development Officer at Akero Therapeutics - South San Francisco, CA, US

Kitty Yale's Colleagues at Akero Therapeutics
Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

Yuan Xu

Independent Board Director

Contact Yuan Xu

Kimberly Barrett

Associate Director, Clinical Data Management

Contact Kimberly Barrett

Jessie Yan

Assistant Controller

Contact Jessie Yan

John Schembri

Vice President Finance

Contact John Schembri

View All Kitty Yale's Colleagues
Kitty Yale's Contact Details
HQ
650-487-6488
Location
Company
Akero Therapeutics
Kitty Yale's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Kitty Yale
Kitty Yale currently works for Akero Therapeutics.
Kitty Yale's role at Akero Therapeutics is EVP and Chief Development Officer.
Kitty Yale's email address is ***@akerotx.com. To view Kitty Yale's full email address, please signup to ConnectPlex.
Kitty Yale works in the Biotechnology industry.
Kitty Yale's colleagues at Akero Therapeutics are Brittany De Temple, Yuan Xu, Kimberly Barrett, Whitney Withington, Jessie Yan, Mark Iwicki, John Schembri and others.
Kitty Yale's phone number is 650-487-6488
See more information about Kitty Yale